![Alain Parthoens](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alain Parthoens
Director/Board Member at
ACTICOR BIOTECH
Profile
Alain Parthoens is the founder.
Mr. Parthoens is the founder of Newton Biocapital Partners SRL, holding the title of Managing Partner since 2017.
Mr. Parthoens is the founder of Epics Therapeutics SA, holding the title of Director since 2018.
Mr. Parthoens is also the founder of Vesalius Biocapital II Partners SARL. Current jobs include Director at Tibotec Virco NV, Non-Executive Director at Ogeda SA, Director & Managing Partner at Biotechnological Enzymatic Catalyse NV, Director at Voluntis SA, Non-Executive Director at Apitope Technology (Bristol) Ltd., Director at Profibrix BV since 2011, Director at Maize Technologies International GmbH, Director at The Belgian Venture Capital & Private Equity Association, Director at PROMETHERA Biosciences SA, Director at Acticor Biotech SAS since 2018, Director at Ncardia Holding SA since 2021, Managing Partner at Vesalius Biocapital Partners SARL, President at Dim3 SA, and Manager at AQ Invest BV.
Former jobs include Director at Cellaïon SA, Director at TiGenix NV, Director at MDxHealth SA from 2003 to 2009, Director at CropDesign NV, Director at Unibioscreen SA, Director at Pluriomics BV, Director at Bio-Sourcing SA, Director at Ncardia SA, Manager at AQ Partners SRL, and Manager at A Q Invest SRL.
Education includes a graduate degree from Université Libre de Bruxelles, a graduate degree from Université Catholique de Louvain, and an undergraduate degree from Solvay Business School of Economics & Management.
Alain Parthoens active positions
| Companies | Position | Start |
|---|---|---|
| VOLUNTIS S.A. | Director/Board Member | - |
| ACTICOR BIOTECH | Director/Board Member | 2018-10-23 |
Ncardia Holding SA
 Ncardia Holding SA BiotechnologyHealth Technology Provides biotech research and development, business management consulting, technical testing & administrative services | Director/Board Member | 2021-11-11 |
Vesalius Biocapital II Partners SARL | Founder | - |
Epics Therapeutics SA
 Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Founder | 2018-02-19 |
Newton Biocapital Partners SRL
 Newton Biocapital Partners SRL Investment ManagersFinance Newton Biocapital Partners SPRL is an active manager which invests in companies located in Belgium, Netherlands, Germany, France and Japan. It participates in early stage and seed stage transactions and focuses on sectors such as Health Technology. | Founder | 2017-04-03 |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases | Director/Board Member | - |
Ogeda SA
 Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Director/Board Member | - |
Vesalius Biocapital Partners SARL
 Vesalius Biocapital Partners SARL Investment ManagersFinance Vesalius Biocapital Partners invests in companies located in Europe. The firm targets companies operating in the fields of life science, therapeutics, medical devices and diagnostics sectors. It provides financing for seed, early and later stage capital requirements with an investment size of up to USD 10 million. It acts as a lead & co-investor and acquires majority interest and also takes a seat on the board of directors. | Private Equity Investor | - |
| ░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Former positions of Alain Parthoens
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Alain Parthoens
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
53
1st degree connections
30
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 30 |
|---|---|
TiGenix NV
 TiGenix NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing and commercializing novel therapeutic | Health Technology |
MDxHealth SA
 MDxHealth SA Medical SpecialtiesHealth Technology Develops and commercializes epigenetic tests & services for cancer assessment | Health Technology |
Tibotec Virco NV
 Tibotec Virco NV Miscellaneous Commercial ServicesCommercial Services Develops drugs and individualized disease management products | Commercial Services |
CropDesign NV
 CropDesign NV Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops traits for cereal crops | Commercial Services |
Université Libre de Bruxelles
 Université Libre de Bruxelles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Health Technology |
Unibioscreen SA
 Unibioscreen SA Pharmaceuticals: MajorHealth Technology Discovers and develops oncology drugs | Health Technology |
Biotechnological Enzymatic Catalyse NV
 Biotechnological Enzymatic Catalyse NV Food: Major DiversifiedConsumer Non-Durables Develops, produces and commercializes enzymatic systems for food preservation | Consumer Non-Durables |
Université Catholique de Louvain
 Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vesalius Biocapital Partners SARL
Vesalius Biocapital Partners SARL Investment ManagersFinance Vesalius Biocapital Partners invests in companies located in Europe. The firm targets companies operating in the fields of life science, therapeutics, medical devices and diagnostics sectors. It provides financing for seed, early and later stage capital requirements with an investment size of up to USD 10 million. It acts as a lead & co-investor and acquires majority interest and also takes a seat on the board of directors. | Finance |
Voluntis SA
 Voluntis SA Packaged SoftwareTechnology Services Develops anti-cancer treatment platform | Technology Services |
Apitope Technology (Bristol) Ltd.
 Apitope Technology (Bristol) Ltd. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic vaccines and diagnostics for autoimmune and allergic diseases | Commercial Services |
ProFibrix BV
 ProFibrix BV BiotechnologyHealth Technology Develops and markets products for the hemostasis and regenerative medicine markets | Health Technology |
Maize Technologies International GmbH | |
The Belgian Venture Capital & Private Equity Association
 The Belgian Venture Capital & Private Equity Association Miscellaneous Commercial ServicesCommercial Services Operates venture capital and private equity association | Commercial Services |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases | Health Technology |
AQ Invest BV | |
Vesalius Biocapital II Partners SARL | |
Solvay Business School of Economics & Management
 Solvay Business School of Economics & Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pluriomics BV
 Pluriomics BV BiotechnologyHealth Technology Research and development of pharmaceuticals | Health Technology |
Bio-Sourcing SA
 Bio-Sourcing SA BiotechnologyHealth Technology Develops and markets biological drugs for veterinary use | Health Technology |
Acticor Biotech SAS
 Acticor Biotech SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development of pharmaceutical products | Commercial Services |
DIM3 SA
 DIM3 SA Packaged SoftwareTechnology Services Develops decision support application software and medical devices for screening and follow-up of disease-related malnutrition | Technology Services |
Ncardia SA
 Ncardia SA Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery research organization | Commercial Services |
Newton Biocapital Partners SRL
Newton Biocapital Partners SRL Investment ManagersFinance Newton Biocapital Partners SPRL is an active manager which invests in companies located in Belgium, Netherlands, Germany, France and Japan. It participates in early stage and seed stage transactions and focuses on sectors such as Health Technology. | Finance |
AQ Partners SRL | |
Epics Therapeutics SA
Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Commercial Services |
Promethera Therapeutics SA
 Promethera Therapeutics SA Pharmaceuticals: OtherHealth Technology Provides cell therapies for treatment of liver diseases | Health Technology |
Ncardia Holding SA
Ncardia Holding SA BiotechnologyHealth Technology Provides biotech research and development, business management consulting, technical testing & administrative services | Health Technology |
A Q Invest SRL |
- Stock Market
- Insiders
- Alain Parthoens
